NDC 14783-830-01 - ESIKA PRO PERFECT MATCH VOLUMEN SPF 20 PLUS LIP LINER FOR MAXIMUM FULLNESS - (FRESA TENTACION) - RED
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 14783-830
- Requested NDC
- 14783-830-01
- Package NDCs from labels
- 14783-830-01, 14783-830-02
- Manufacturer
- Ventura International LTD | Bel Star S.A. (Colombia)
- Effective date
- 2017-09-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Octinoxate - Ventura International LTD | Bel Star S.A. (Colombia) | Ventura International LTD | Bel Star S.A. (Colombia) | 2017-09-06 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 14783-830-02 | 2025-03-14 | C162847 | 48780-1 | 9d75b9d0-8cda-f424-e053-dadaa90a57ce | ESIKA PRO PERFECT MATCH VOLUMEN LIPSTICK SPF 20 + LIP LINER FOR MAXIMUM FULLNESS |
| 14783-830-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8cda-f424-e053-dadaa90a57ce | ESIKA PRO PERFECT MATCH VOLUMEN LIPSTICK SPF 20 + LIP LINER FOR MAXIMUM FULLNESS |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Renewal Firming Day Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | BURT'S BEES, INC. | 18ceb5d8-4b76-6a54-e054-00144ff88e88 | 2015-06-18 | Warnings | 15FIX9V2JP |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD. | 30468afc-9616-4765-b046-12e97a0a7827 | 2010-12-20 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.